| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |